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Abstract: Robustness is deﬁ  ned as the ability to uphold performance in face of perturbations and uncertainties, and sensitivity 
is a measure of the system deviations generated by perturbations to the system. While cancer appears as a robust but fragile 
system, few computational and quantitative evidences demonstrate robustness tradeoffs in cancer. Microarrays have been 
widely applied to decipher gene expression signatures in human cancer research, and quantiﬁ  cation of global gene expres-
sion proﬁ  les facilitates precise prediction and modeling of cancer in systems biology. We provide several efﬁ  cient compu-
tational methods based on system and control theory to compare robustness and sensitivity between cancer and normal cells 
by microarray data. Measurement of robustness and sensitivity by linear stochastic model is introduced in this study, which 
shows oscillations in feedback loops of p53 and demonstrates robustness tradeoffs that cancer is a robust system with some 
extreme fragilities. In addition, we measure sensitivity of gene expression to perturbations in other gene expression and 
kinetic parameters, discuss nonlinear effects in feedback loops of p53 and extend our method to robustness-based cancer 
drug design.
Keywords: robustness tradeoffs, sensitivity analysis, robustness-based cancer drug design, feedback loops of p53
Introduction
Robustness is a measure of the system behavior or performance in face of perturbations and uncertain-
ties, and sensitivity is a measure of the system deviations generated by perturbations to the system, for 
instance, environmental stress (Chen et al. 2005; Stelling et al. 2004; Weinmann, 1991). Since robust-
ness or sensitivity is an essential property of biological systems, the general concept has been proposed 
recently (Kitano, 2004a; Stelling et al. 2004), and several analytical methods of robustness and sensitiv-
ity have been recently developed (Chen et al. 2005; Sontag et al. 2004). Many studies discuss robustness 
and sensitivity from theories to experiments, for example, researchers design robust bacterial signaling 
networks based on the control theory to adapt to the environment (Kollmann et al. 2005), and some 
studies design ﬁ  lters to regulate variations and preserve robustness (Chen and Wang, 2006).
Cancer is a complex system caused by multiple gene mutations including oncogenes and tumor-
suppressor genes (Vogelstein and Kinzler, 2004). Tumors preserve cellular diversity which facilitates 
robustness through homogeneous and heterogeneous redundancies and feedback loops (Kitano, 2004b). 
For example, transcriptional activation of the tumor suppressor gene p53 produces several positive and 
negative autoregulatory feedback loops that interact with many other signal transduction pathways 
(Harris and Levine, 2005). Multiple feedback loops provide redundancies, strengthen robustness and 
reduce phenotype variations (Stelling et al. 2004). Tumors are highly robust to maintain their prolif-
eration potential against a wide range of anticancer therapies, which are exploited by robustness-
functional redundancy and feedback-control systems (Kitano, 2004b). Multiple feedback loops of p53, 
for example, can prevent errors and reduce the phenotype of mutations (Harris and Levine, 2005).
Deﬁ  nition of sensitivity in systems control theory is the reciprocal of robustness (Chen et al. 2005; 
Voit and Ferreira, 2000), which can help designers evaluate perturbated gene expression by environ-
mental stress. Cancer displays the ‘robust yet fragile’ property, that is, robustness tradeoffs, because 
cancer gains robust abilities to anti-growth signals but hypersensitive functions to tissue invasion (Kitano, 
2004b). The tradeoffs among robustness, fragility, and complexity dominate design procedure of many 
engineering systems, and now the theoretical foundation for a systems-oriented drug design has been 
recently developed. A drug target can be effective if it hits the point of fragility, and tradeoffs among 
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robustness, fragility, and complexity dominate the 
theoretical foundation for a systems-oriented drug 
design (Carlson and Doyle, 2002; Chen and Li, 
2007; Kitano, 2004b, 2007). While robustness 
tradeoffs in biological organisms have been 
discussed recently and control theories have been 
proposed for a long time, quantitative conﬁ  rmation 
of robustness by system control theory in cancer 
research is necessary.
Through the progression of the large-scale 
experiment, the complexity and multiple factors 
in cancer cells seem feasible to detect and mea-
sure. The large-scale sequencing approach such 
as microarray technology identiﬁ  es several previ-
ous unknown mutations, giving us whole genome 
expression proﬁ  les to detect gene expressions and 
target genes. Most computational analysis of the 
microarray data relies on clustering which broadly 
classiﬁ  es genes’ functions into subgroups but 
hides many possible transcription factors (Barenco 
et al. 2006). Moreover, the clustering approach 
cannot describe systematic behavior of the gene 
regulatory circuits such as robustness and sensi-
tivity (Sontag et al. 2004). Mathematical model-
ing, on the contrary, could sketch the wiring 
diagrams of cellular signaling pathways in this 
‘integrated circuit of the cell’ (Hanahan and 
Weinberg, 2000).
The systems biology approach by microarray 
data and mathematical models is powerful to mea-
sure robustness and sensitivity in cancer cells, one 
of the most important issues in robustness-based 
drug target design (Hornberg et al. 2006; Kitano, 
2007). Although the concept of robustness trad-
eoffs has been proposed (Kitano, 2004a, b, 2007; 
Stelling et al. 2004), few studies calculate 
robustness and sensitivity in cancer quantitatively. 
In this study, we use linear discrete stochastic 
model from microarray data to analyze robustness 
and sensitivity in feedback loops of p53 by system 
control theory and extend our results to robustness-
based cancer drug design.
Methods
Selecting and processing 
experimental data
The p53 tumor suppressor gene is described as ‘the 
guardian of the genome’, which prevents mutagen-
esis and carcinogenesis by promoting cell-cycle 
arrest or apoptosis (Vogelstein and Kinzler, 2004; 
Vousden and Lu, 2002). Therefore, we choose p53 
as our example to display robustness properties in 
cancer cells. Microarray data is collected from 
Barenco et al. (2006), in which human leukemia 
cell lines (MOTL4) containing functional p53 are 
irradiated at 0, 2, 4, 6, 8, 10, 12 hours in triplicate. 
Due to multiple feedback loops of p53 that deter-
mine systematic robust behavior (Kitano, 2004b), 
genes of the multiple positive or negative feedback 
networks are primarily considered in our analysis 
of robustness of p53.
To inquire into systematical analysis of sensi-
tivity under diverse stresses upon the p53 system, 
we apply the microarray data of HeLa cervical 
carcinoma cells and primary human lung ﬁ  bro-
blasts to heat shock, oxidative stress, and endo-
plasmic reticulum (ER) stress (Murray et al. 
2004). We induced heat shock by transferring 
culture ﬂ  asks from a 37 °C incubator to a 42 °C 
incubator. ER stress was induced by treating HeLa 
cells or ﬁ  broblasts with 2.5 mM dithiothreitol 
(DTT). Oxidative stress was induced by treating 
HeLa cells or ﬁ  broblasts with 10 µM menadione 
bisulfate. Time points are sampled as 0, 0.5, 1, 2, 
3, 4, 6, 8, 24 hours in cancer cells and 0, 0.5, 1, 
2, 4, 10, 16, 24 hours in normal cells under heat 
stress, compared to 0, 0.5, 1, 2, 4, 8, 12, 24 hours 
in cancer cells and 0, 0.5, 1, 3, 4, 6, 8, 12, 24 hours 
in normal cells under oxidative stress, and 0, 0.5, 
1, 2, 4, 6, 8, 16, 24 in cancer cells and 0, 0.5, 1, 
2, 3, 4, 6, 8, 12, 16, 24 in normal cells under 
ER stress.
Robustness analysis in feedback 
loops of p53
Assume the gene regulatory network contains M 
genes, and time-series microarray data contains N 
time samplings. The system is modeled as:
  xt A xt k t [ ] [] [] += ++ 1 ε   (1)
where xt x t x t x t M
T [] [ () () () ] = 12    ...   denotes mRNA 
levels of total M genes at time point t = 1 … N. k  
stands for the basal level from other intrinsic and 
extrinsic pathways, and ε[] t  represents stochastic 
events such as modeling errors, intrinsic and extrin-
sic noises (Chen and Wang, 2006). We use the least 
square estimation method to estimate the interaction 
matrix A in equation (1) from time-series microar-
ray data as
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where αi,j denotes the interaction from gene j to 
gene i when i ≠ j, ∀i, j = 1… M.
Based on system theory (Weinmann, 1991), the 
eigenvalues λi, i = 1 … M in equation (2) determine 
the stability of the network. If eigenvalues of A 
are all inside the unit circle of the z-complex 
domain (that is, |λi|  1), the network is stable; if 
at least one eigenvalue is outside the unit circle 
(that is, |λi|  1), the network is unstable; if some 
eigenvalues are on the unit circle (that is, |λi| = 1), 
the network will be oscillated. If all eigenvalues 
are more near the origin of the z complex domain, 
the network is more robust because its eigenvalues 
are not easily perturbed outside the unit circle.
Sensitivity analysis of cancer 
and normal cells under stresses
Sensitivity is the reciprocal of robustness which 
measures the system response to external distur-
bance (Voit and Ferreira, 2000). In this study, we 
introduce three methods to measure sensitivity in 
different meanings: sensitivity of perturbations in 
gene expression to external stress, sensitivity of 
gene expression to the perturbations in other gene 
expression, and sensitivity of gene expression to 
changes in kinetic parameters.
We can describe a system with external distur-
bances as
  xt A xt B ut k [] [ ] [] += + −++ 11 ε   (3)
where xt [] denotes the gene expression proﬁ  les at 
time t measured in the microarray, ut [] −1  denotes 
an environmental stress on the system at time t − 1 
with one time delay, k  represents the basal level 
from other unconsidered inﬂ  uence, and ε[] t  rep-
resents stochastic events such as intrinsic and 
extrinsic noises. We also apply the least square 
estimation algorithm (Johansson, 1993) to obtain 
parameters of A and B by microarray data. ut [] −1  
is considered as a step function which represents 
constant environmental stress to the gene regula-
tory circuits with time delay in response.
Sensitivity of the gene expression for 
perturbations in environmental stress
The sensitivity for the input stress could be 
derived as
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where ∆ means a small perturbation in discrete time 
system, and 
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In equation (5), S(t) is time-dependent func-
tion which reflects the sensitivity to perturba-
tions at different time samplings, which 
represent the system variations to unit-step input 
perturbations. For clarity and simplicity in com-
parison with sensitivity scores of M genes in 
cancer cells with those in normal cells, we 
define the sensitivity score of each gene as the 
average of equation (5)
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Sensitivity of gene expression 
to the perturbations in other 
gene expression
Besides sensitivity analysis in equations (3)–(6) 
that measure changes in a system state with respect 
for environmental perturbations, the relative 
change of a system variable in response to a rela-
tive change in the other system variables is also 
important in analyzing sensitivity and robustness 
(Voit and Ferreira, 2000). In other words, measure-
ment of  xt [] +1  to  xt []  can represent stability 
of the system. Since 
 
 
k
xt []= 0and   
 
ε
xt []= 0, we gain 
sensitivity of the perturbated gene expression from 
equation (3) as
Cancer Informatics 2008:6168
Chu and Chen
 
St
xt
xt
AB
ut
xt
xt
xt
()
[]
[]
[]
[]
[]
[]
 
 
 
 
 
i
 
 
+
=+
−
+
+ 11
1
1
 
(7)
Therefore, sensitivity of the perturbated gene 
expressions is
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In general, 
 
 
ut
xt
[]
[]
−
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1
1 0 because the control input 
ut [] −1  is independent of state vector xt [] +1  
except the control input is based on state feedback. 
In this situation, 
 
 
ut
xt
[]
[]
−
+ =
1
1 0 because perturbation of 
gene expression xt [] +1  should be independent of 
control input as extracellular stress ut [] −1 . So, we 
approximate equation (8) as
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It is noticed S(t) is approximate to A in equation 
(3) if we consider 
 
 
ut
xt
[]
[]
−
+ =
1
1 0. Hence, A primarily 
determines stability and robustness of the system, 
which coordinates with robustness analysis in 
equations (1)–(2). If all the eigenvalues λi of A are 
inside the unit circle in z-complex domain, the 
propagation of perturbations of concentration of 
genes will converge to zero constant. On the other 
hand, if some eigenvalues λi of A are outside the 
unit circle in z-complex domain, perturbations in 
the concentrations of some genes will deteriorate 
or amplify in the gene network. If some eigenval-
ues of the network are near the unit circle, then the 
perturbation of some gene units will keep propaga-
tion in the gene circuit.
Sensitivity of gene expression 
to perturbations of parameter A
In this method, sensitivity is used to estimate the 
effect of variations of parameters A in equation (1). 
However, we can not directly calculate 
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A
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within M genes from equation (3) by the deﬁ  nition 
in Weinmann (1991).
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In equation (10), ⊗ denotes Kronecker product 
and Ei,j denotes Kronecker matrix (Weinmann, 
1991). By matrix product rule, we can derive 
equation (10) from equation (3) as
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For simplicity in comparison with the sensitiv-
ity of gene expression to each  Ai, j, ∀i, j = 1 … M,  
we deﬁ  ne the sensitivity score Si, j of each  Ai, j as 
the average of equation (10) or (11), that is,
(10)
(11)
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All the simulations are with MATLAB 7.1, and 
the programs can be requested by email to the 
authors. Cubic spline interpolation is also used in 
the simulation to obtain sufﬁ  cient time samplings 
in the silico simulation and parameter estimation 
without data overﬁ  tting or deviating data (Chang 
et al. 2005).
Results
Construction of multiple feedback 
loops of p53 pathway
The P53 protein and its signal transduction pathway 
are composed of a set of genes and their protein 
products that are designed to respond to a wide variety 
of intrinsic and extrinsic stress signals (Vogelstein 
and Kinzler, 2004). We combine several literature to 
construct p53 feedback regulatory network within 
seven feedback loops (Fodde et al. 2001; Harris and 
Levine, 2005; Sherr, 2006; Sherr and McCormick, 
2002; Vivanco and Sawyers, 2002; Vousden and 
Lu, 2002) including sixteen genes, namely p53, ARF, 
MDM2, p21, cdk2, Rb, MAPK14, Wip-1, Siah-1, 
β-catenin, PTEN, PIP3, AKT2, CCNG1, PP2A, and 
p73 (shown in Fig. 1).
Loop1: p53/ MDM2/ ARF. p53 transcriptionally 
activates MDM2, while activated MDM2 targets 
p53 by both inhibiting its activity as a transcription 
factor and enhancing its degradation rate (p53 → 
MDM2 –| p53). The concentration of p53 increases 
in response to stress signals such as DNA damage, 
while different stress signals undergo distinct 
pathways to allow p53 to escape MDM2-mediated 
protein degradation (Harris and Levine, 2005; 
Toledo and Wahl, 2006). The ARF tumor suppres-
sor gene plays an important role in cell cycle 
regulation or apoptosis by controlling MDM2 and 
Figure 1. Multiple feedback loops of p53 pathway. Several positive, negative and autoregulatory feedback loops are illustrated. These 
sixteen genes in p53 pathway are: p53, ARF, MDM2, p21, cdk2, Rb, MAPK14, Wip-1, Siah-1, β-catenin, PTEN, PIP3, AKT2, CCNG1, 
PP2A, and p73.
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p53 levels (ARF –| MDM2 –| p53). Transcription 
of the ARF gene is positively regulated by 
β-catenin and negatively regulated by p53 itself, 
and ARF protein binds to the MDM2 protein and 
increase the level of P53 protein (Sherr, 2006).
Loop2: p21/Cyclin E-cdk2/Rb/MDM2. The 
p53 transcription factor is induced in response to 
DNA damage and oncogene activation, and p53 
regulates a set of genes either related to cell cycle 
arrest or apoptosis such as p21. p21 and p27 are 
the Cip/Kip family of cyclin-dependent kinase 
inhibitor that inhibits cyclin E-cdk2 complex, 
which phosphorylates and inhibits both Rb and 
MDM2 (Sherr and McCormick, 2002). Rb directly 
binds to MDM2 to antagonize these functions and 
then inhibits p53 activity.
Loop3: Wip-1/MAPK14. Wip-1 is a p53 respon-
sive gene forming a negative autoregulatory loop 
connecting the p53 and Ras pathways, which also 
dephosphorylates and inactivates MAPK14 
(p38MAP kinase). MAPK14 is also regulated 
through the Ras signaling cascade and mediates 
phosphorylation of p53 in response to UV irradia-
tion (Vousden and Lu, 2002).
Loop4: Siah1/β-catenin/ARF. The activated P53 
protein positively regulates the transcription of the 
ubiquitin ligase Siah-1 which in turn acts to degrade 
the β-catenin protein. β-catenin can regulate ARF 
which in turn negatively regulates MDM2 and 
results in higher p53 levels (Fodde et al. 2001).
Loop5:  PTEN/ AKT2/ MDM2. In some cell types, 
p53 can positively regulate PTEN, a lipid phosphatase 
that converts PIP3 to PIP2, and then PIP3 activates 
AKT2 kinase which inﬂ  uences cell survival by phos-
phorylation of MDM2 resulting in translocation of 
MDM2 into the nucleus and inactivation of p53. This 
connection forms a positive feedback loop for 
enhancing p53 activity and decreasing AKT2 activity 
(Vivanco and Sawyers, 2002).
Loop6: CCNG1/MDM2. One of the p53-
responsive genes includes cyclin G protein 
(CCNG1), forming a complex with the PP2A phos-
phatase which removes a phosphate residue from 
MDM2. The cyclin G-PP2A phosphatase enhances 
MDM2 activity and inhibits p53 (Sherr, 2006).
Loop 7: p73/ p53-regulated genes. p53 is acti-
vated by environmental stresses and in turn 
stimulates the transcription of a particular spliced 
mRNA from the p73 gene named p73 ∆N. When 
p53 activates the transcription of p73 ∆N, the p73 
∆N protein can bind many of the p53-regulated 
genes, but the absence of a transactivation domain 
makes it act as a repressor or competitor of p53 
transcriptional activation. In this way, a negative 
feedback loop is set up and p53 activity declines 
(Harris and Levine, 2005).
Oscillations in feedback loops 
of p53 pathway
We construct feedback loops of p53 with sixteen 
genes in Figure 1 by literature and plot means and 
standard deviations of the triplicate discrete normal-
ized microarray data in Figure 2. By least square 
error parameter estimation (Johansson, 1993), the 
dynamic model of the sixteen genes in the p53 
feedback network in equation (1) is constructed in 
Table 1 of sixteen genes with estimated parameters 
by microarray data (Barenco et al. 2006). Through 
equations (1)–(2) and Table 1, we calculate sixteen 
eigenvalues of interaction matrix A as follows:
0.75535 0.93762 0.94123  0.9582
0.96792 0.97702 0.97047  0.99848
1.0121 1.0156 0.94887  +  0.94887 −
  0.052618i 0.052618i
0.98245 + 0.98245  − 1.0516+ 1.0516  −
0.0033062i 0.0033062i 0.023984i  0.023984i
The result in Figure 3 illustrates nine real eigen-
values locate near the unit circle (0.93762, 0.94123, 
0.9582, 0.96792, 0.97702, 0.97047, 0.99848, 
1.0121, 1.0156), and six eigenvalues are complex 
conjugate near the unit circle (0.94887 ± 0.052618i, 
0.98245 ± 0.0033062i, 1.0516 ± 0.023984i). In 
other words, ﬁ  fteen eigenvalues of the interaction 
matrix A locate together at the same region near 
the unit circle | z | = 1, which demonstrate oscilla-
tions in the p53 system with almost the same 
frequency or period (Ciliberto et al. 2005; Geva-
Zatorsky et al. 2006; Kitano, 2004b; Lahav et al. 
2004). Four eigenvalues locate a little bit outside 
the unit circle (1.0121, 1.0156, 1.0516 ± 0.023984i) 
because time samplings are only from 0 to 12 hours 
(Barenco et al. 2006) (see Fig. 2), but oscillation 
periods are about 5.5 hours (Geva-Zatorsky et al. 
2006). Inadequate time sampling periods conse-
quently affect measurement of instability, because 
periodic signals are still in their transient states of 
ascending or decaying in ﬁ  nite sampling data, and 
therefore they are considered as unstable signals 
in a ﬁ  nite period of oscillation signals (Brillinger, 
1981). Therefore, based on the above analysis, 
most of the genes in the multiple loops of p53 are 
in oscillation with the same frequency. The slight 
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instability is because of the effect of ﬁ  nite data of 
periodic signals.
Sensitivity of the gene expression 
for perturbated environmental stress
The sensitivity of each gene for the change in 
parameters is considered as the inverse of 
robustness of gene regulatory networks (Chen et al. 
2005; Weinmann, 1991). Environmental stresses 
induce several cellular responses, and p53 plays 
the central role that integrates environmental stress 
and cellular responses (Holcik and Sonenberg, 
2005; Vousden and Lu, 2002). Activation of p53 
by different stress signals such as DNA damage 
and oncogene activation can result in many cellular 
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Figure 2. Mean and standard deviation of gene expressions of sixteen genes in multiple feedback loops of p53.
Table 1. Ordinary difference equations of sixteen genes in feedback loops of p53.
  Gene name  Mathematical description of sixteen genes in feedback loops of p53
x1 p53  x1[t + 1] = α1,1x1[t] + α1,3x3[t] + α1,6x6[t] + α1,7x7[t] + k1 + ε1
x2 ARF  x2[t + 1] = α2,1x1[t] + α2,2x2[t] + α2,10x10[t] + k2 + ε2
x3 MDM2  x3[t + 1] = α3,1x1[t] + α3,2x2[t] + α3,3x3[t] + α3,5x5[t] + α3,6x6[t]
   + α3,13x13[t] + α3,15x15[t] + α3,16x16[t] + k3 + ε3
x4 p21  x4[t + 1] = α4,1x1[t] + α4,4x4[t] + k4 + ε4
x5 cdk2  x5[t + 1] = α5,4x4[t] + α5,5x5[t] + k5 + ε5
x6 Rb  x6[t + 1] = α6,5x5[t] + α6,6x6[t] + k6 + ε6
x7 MAPK14  x7[t + 1] = α7,7x7[t] + α7,8x8[t] + k7 + ε7
x8 Wip-1  x8[t + 1] = α8,1x1[t] + α8,8x8[t] + k8 + ε8
x9 Siah-1  x9[t + 1] = α9,1x1[t] + α9,9x9[t] + k9 + ε9
x10  β-catenin  x10[t + 1] = α10,9x9[t] + α10,10x10[t] + k10 + ε10
x11 PTEN  x11[t + 1] = α11,1x1[t] + α11,11x11[t] + k11 + ε11
x12 PIP3  x12[t + 1] = α12,11x11[t] + α12,12x12[t] + k12 + ε12
x13 AKT2  x13[t + 1] = α13,12x12[t] + α13,13x13[t] + k13 + ε13
x14 CCNG1  x14[t + 1] = α14,1x1[t] + α14,14x14[t] + k14 + ε14
x15 PP2A  x15[t + 1] = α15,14x14[t] + α15,15x15[t] + k15 + ε15
x16 p73  x16[t + 1] = α16,1x1[t] + α16,3x3[t] + α16,14x14[t] + α16,16x16[t] + k16 + ε16
α1,1 = 0.9316; α1,3 = −0.4334; α1,6 = −0.02982; α1,7 = 0.1688; α2,1 = 0.003243; α2,2 = 0.9704; α2,10 = −0.002874; α3,1 = −0.0314; α3,2 = −0.09199; 
α3,3 = 0.8198; α3,5 = 0.05164; α3,6 = −0.1261; α3,13 = 0.3148; α3,15 = 0.07828; α3,16 = −0.08918; α4,1 = 0.02437; α4,4 = 09695; α5,4 = −0.02353; 
α5,5 = 1.054; α6,5 = 0.106; α6,6 = 0.9907; α7,7 = 0.9733; α7,8 = 0.01645; α8,1 = 0.05625; α8,8 = 0.9581; α9,1 = 0.01594; α9,9 = 1.015; α10,9 = 0.02788; 
α10,10 = 0.9582; α11,1 = 0.000767; α11,11 = 1; α12,11 = 0.03649; α12,12 = 1.009; α13,12 = 0.06556; α13,13 = 0.935; α14,1 = 0.05642; α14,14 = 0.9832; 
α15,4 = 0.001754; α15,15 = 0.9765; α16,1 = −0.001995; α16,3 = 0.02613; α16,14 = −0.00162; α16,16 = 0.9525.
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responses including apoptosis, senescence, 
cell-cycle arrest, survival, DNA repair and genomic 
stability (Vousden and Lu, 2002). Therefore, 
we take multiple feedback loops of p53 in Figure 1 
as the example of sensitivity analysis under per-
turbated environmental stress, and calculate sen-
sitivity of the sixteen genes in Figure 1 by 
microarray data between cancer and normal cells 
under heat shock, oxidative and endoplasmic 
reticulum (ER) stress (Murray et al. 2004). Detailed 
mathematical description and estimated parameters 
of the sixteen genes under environmental stresses 
in equation (3) are listed in Table 2 and Supple-
mentary Table 1.
Although cancer conceptually appears to be a 
robust but fragile system, few computational and 
quantitative evidences support robustness tradeoffs 
in the cancer system. To gain objective compari-
sons between cancer and normal cells, we unify 
the comparative conditions between cancer and 
normal cells. First, we only calculate microarray 
data for 24 hours to reduce biased comparisons 
caused by different time intervals. Next, we unify 
perturbations in this study as normal distributed 
noises with zero mean and 0.1 standard deviations. 
Moreover, we simulate each interpolated time 
sampling as 1,000 times and then take the median 
of these 1,000 sensitivity values because some 
extreme values will cause deviations. For simplicity 
in comparisons of these sixteen genes between 
cancer and normal cells under different stresses, 
we take the average of this time-dependent 
sensitivity in equation (6) and list the sensitivity 
scores in Table 3. Table 3 illustrates comparisons 
of sensitivity scores among genes in the regulatory 
network with ranking, where bold and red marks 
stand for the genes with a higher sensitivity value 
under each of the three stresses between cancer 
and normal cells.
Sensitive genes in multiple feedback 
loops of p53 between cancer and 
normal cells
Multiple feedback loops heighten robustness of 
tumors at intracellular levels, which can result in 
robustness against chemotherapy (Kitano, 2004b). 
When MDM2 is degraded to upregulate p53 activ-
ity, activated p53 also activates MDM2 which 
negatively regulates p53 and forms the autoregula-
tory feedback loop (Geva-Zatorsky et al. 2006). 
Over-expression of MDM2 in cancer cells causes 
degradation of p53 and evades apoptosis (Harris 
and Levine, 2005). In Table 3, p53 and MDM2 are 
the two genes with high sensitivity scores in normal 
cells under different stresses, which shows that 
Figure 3. Plot of the sixteen eigenvalues in multiple feedback loops of p53. Fifteen eigenvalues are located near the unit circle, strongly 
indicating that p53 system is oscillated.
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these diverse cellular stress signals all feed into 
this p53-MDM2 autoregulatory feedback loop. 
Transcription factor p53 responds to diverse 
stresses and regulates many target genes, and 
MDM2 inhibits p53 in normal conditions (Harris 
and Levine, 2005; Levine et al. 2006; Toledo and 
Wahl, 2006). Multiple feedback redundancies of 
p53 form the bow-tie architecture, which is robust 
at systems level but fragile on essential elements 
such as p53 and MDM2 (Kitano, 2007). Some 
extreme values in normal cells such as PP2A under 
heat shock, MAPK14 under oxidative stress, and 
CCNG1 might be triggered fragilely by signal 
transduction (Harris and Levine, 2005).
Although p53 is not the gene with the highest 
sensitivity score in cancer cells, MDM2 has 
extremely high sensitivity score in cancer cells 
under heat shock, oxidative and ER stress (See 
Table 3). Since cancer cells lose control abilities 
under these stresses which result in loss of ﬁ  delity 
in cellular duplication process, P53 and MDM2 
proteins are extensively modiﬁ  ed after a stress 
signal between this autoregulatory feedback loop 
(Geva-Zatorsky et al. 2006; Lahav et al. 2004; 
Levine et al. 2006). We demonstrate that p53 is 
activated as the central node in normal cells but not 
in cancer cells under perturbated environmental 
stresses, because p53 is mutated about 50% of a 
wide variety of cancers (Levine et al. 2006). 
Loss-of-function mutations of p53 in cancer are 
strongly associated with an increased susceptibility 
to cancer, and most functions of p53 have been con-
sidered in the light of how p53 might help prevent 
malignant progression (Vousden and Lane, 2007).
Sensitive genes in multiple feedback 
loops of p53 under different stresses
Stress signals all affect upon the cellular homeo-
static mechanisms that monitor and control the 
ﬁ  delity of DNA replication, chromosome segrega-
tion and cell division (Herr and Debatin, 2001). 
Stresses that activate p53 include damage to the 
integrity of DNA in a cell, UV irradiation, DNA 
cross-linking, reaction with oxidative free radicals 
and heat shock, etc (Levine et al. 2006). Therefore, 
comparisons of sensitive genes can clearly depict 
the mechanisms of p53 activation under different 
stresses. However, we cannot directly compare the 
value of sensitivity scores under different stresses 
due to different experimental procedures. There-
fore, we compare three genes with the highest 
sensitivity scores among sixteen genes under three 
stresses in Table 3.
Since a drug can be effective if it hits the point 
of fragility (Kitano, 2007), we compare three 
genes with highest sensitivity scores and ﬁ  nd 
extreme fragility under different stresses. In a 
Table 2. Ordinary difference equations of sixteen genes in feedback loops of p53 under stresses. Estimated 
parameters are in Supplementary Table 1.
  Gene name  Mathematical description of sixteen genes under stresses
x1 p53  x1[t + 1] = α1,1x1[t] + α1,3x3[t] + α1,6x6[t] + α1,7x7[t] + β1u[t − 1] + k1 + ε1
x2 ARF  x2[t + 1] = α2,1x1[t] + α2,2x2[t] + α2,10x10[t] + β2u[t − 1] + k2 + ε2
x3 MDM2  x3[t + 1] = α3,1x1[t] + α3,2x2[t] + α3,3x3[t] + α3,5x5[t] + α3,6x6[t]
   + α3,13x13[t] + α3,15x15[t] + α3,16x16[t] + β3u[t − 1] + k3 + ε3 
x4 p21  x4[t + 1] = α4,1x1[t] + α4,4x4[t] + β4u[t − 1] + k4 + ε4
x5 cdk2  x5[t + 1] = α5,4x4[t] + α5,5x5[t] + β5u[t − 1] + k5 + ε5
x6 Rb  x6[t + 1] = α6,5x5[t] + α6,6x6[t] + β6u[t − 1] + k6 + ε6
x7 MAPK14  x7[t + 1] = α7,7x7[t] + α7,8x8[t] + β7u[t − 1] + k7 + ε7
x8 Wip-1  x8[t + 1] = α8,1x1[t] + α8,8x8[t] + β8u[t − 1] + k8 + ε8
x9 Siah-1  x9[t + 1] = α9,1x1[t] + α9,9x9[t] + β9u[t − 1] + k9 + ε9
x10  β-catenin  x10[t + 1] = α10,9x9[t] + α10,10x10[t] + β10u[t − 1] + k10 + ε10
x11 PTEN  x11[t + 1] = α11,1x1[t] + α11,11x11[t] + β11u[t − 1] + k11 + ε11
x12 PIP3  x12[t + 1] = α12,11x11[t] + α12,12x12[t] + β12u[t − 1] + k12 + ε12
x13 AKT2  x13[t + 1] = α13,12x12[t] + α13,13x13[t] + β13u[t − 1] + k13 + ε13
x14 CCNG1  x14[t + 1] = α14,1x1[t] + α14,14x14[t] + β14u[t − 1] + k14 + ε14
x15 PP2A  x15[t + 1] = α15,14x14[t] + α15,15x15[t] + β15u[t − 1] + k15 + ε15
x16 p73  x16[t + 1] = α16,1x1[t] + α16,3x3[t] + α16,14x14[t] + α16,16x16[t] + β16u[t − 1] + k16 + ε16
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cancer cell, the three genes with the highest scores 
are MDM2, p73, and p21 under heat shock, as 
well as p73, MDM2 and Siah-1 under oxidative 
stress, and MDM2, ARF and p73 under ER stress. 
In a normal cell, the three genes with the highest 
sensitivity scores are MDM2, p21, and PP2A 
under heat shock, as well as MAPK14, p53 and 
MDM2 under oxidative stress and CCNG1, p53 
and MDM2 under ER stress (See Table 3). The 
likeliness between cancer and normal cells is that 
MDM2 is always the gene with high sensitivity 
score, but p53 is sensitive only in normal cells 
compared with p73 in cancer cells. p73 is an 
example of fragility in the cancer system, since 
sensitivity of p73 is much higher than other genes 
in the cancer cell. In other words, p73 is a good 
drug target by its fragility in cancer but not in 
normal cells for cancer drug target discovery 
(Chen and Li, 2007; Kitano, 2007). Since rankings 
of sensitive genes in under the three stresses are 
all distinct in Table 3, we can also conclude that 
different stress signals will induce different 
responses (Vousden and Lane, 2007).
Cancer: the robust but fragile system
Cancer is a robust system that prevents apoptosis 
but also a fragile (or sensitive) system that promotes 
cell cycle progression and metastasis (Kitano, 
2004a, b, 2007; Stelling et al. 2004). In Table 3, 
sensitivity scores of p53 under heat shock, oxidative 
and ER stress in normal cell are 0.554, 0.289 and 
0.488, which are higher than 0.074, 0.05, 0.046 in 
cancer cells under the three stresses, respectively. 
Because p53 is seemed as ‘the guardian of the 
genome’, sensitivity scores of p53 which are higher 
in normal cells than in cancer cells indicate cancer 
is a less sensitive or more robust system. Besides, 
genes with higher sensitivity scores in normal cells 
than in cancer cells include p53, MDM2, p21, 
MAPK14, Wip-1, Siah-1, β-catenin, AKT2, 
CCNG1, PP2A and p73 under heat shock, 
p53, ARF, p21, Rb, MAPK14, Wip-1, Siah-1, PIP3, 
AKT2, CCNG1 and PP2A under oxidative 
stress, and p53, p21, Rb, Wip-1, β-catenin, PTEN, 
PIP3, AKT2 and CCNG1 under ER stress (see 
Table 3 with red and bold marks). In other words, 
there are more than half of the sixteen genes in 
feedback loops of p53 with higher sensitivity scores 
in normal cells under heat shock, oxidative and ER 
stress. Since p53 and half of the sixteen genes in 
Figure 1 are less sensitive or more robust in cancer 
cells than in normal cells under the three stresses, 
we can conclude that cancer is a ‘more robust’ 
system compared with normal cell. Hence, we not 
only demonstrate the robust but fragile property in 
cancer cell but also clearly illustrate sensitivity and 
robustness of each gene between cancer and normal 
cells, which help the identiﬁ  cation of cancer drug 
target discovery (Kitano, 2007).
Sensitivity of gene expressions 
to the perturbations in other 
gene expression
Measurement of the perturbated system  xt [] +1  
caused by small input perturbation  xt []  could 
analyze stability and robustness in equations 
(7)–(9). Estimated parameter A in Table 2 and 
Supplementary Table 1 determines the stability and 
robustness of the system, and eigenvalues of A 
listed in Table 4 determine stability in the gene 
network. According to the system theory, perturba-
tions of some genes will propagate in the gene 
network if some eigenvalues of the network are 
near the unit circle.
In Table 4, we can observe that some eigenval-
ues in both cancer and normal cells under different 
stresses are near the unit circle. The number of the 
complex magnitude of eigenvalues 0.95 or 
1.05 in normal cell is 5, 9 and 10, as well as 8, 
10 and 11 in cancer cell under heat shock, oxidative 
and ER stress, respectively. Therefore, we conclude 
that perturbations of some genes will be kept in 
the gene circuit network for a long time both in 
cancer and normal cells. In fact, we use the linear 
stochastic model in this study, but nonlinearity 
exists ubiquitously in biological systems. The 
advantage of the linear model is its simplicity and 
effectiveness, but it neglects the effects of nonlin-
earity of the p53 pathway. Therefore, sensitivity 
of the gene expression to the perturbations in other 
gene expression in the p53 system indicates the 
existence of these nonlinear effects in p53 feedback 
loops, which cannot be interpreted by linear gene 
network and it needs further analysis.
Sensitivity of gene expression 
to changes in kinetic parameters
The sensitivity of gene expression to ∆A in equa-
tions (10)–(12) could measure how strongly the 
gene expression is affected by perturbations in 
kinetic parameters. This method could measure 
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which perturbated parameters cause the system 
the most serious variations. In other words, we 
can indicate which genes are the most sensitive to 
the perturbated parameters by this method. We 
illustrate our result as the sensitivity scores in 
cancer cells under heat shock in Supplementary 
Table 2.
Heat shock results in the phosphorylation of 
eukaryotic initiator factor 2α, inhibition of global 
translation and induction of stress responses 
(Holcik and Sonenberg, 2005). Since thermal per-
turbations by heat shock lead to dramatic changes 
in kinetic parameters, equations (10)–(12) and 
Supplementary Table 2 provide useful information 
in the estimated inﬂ  uence of perturbated kinetic 
parameters. First, we can estimate degree of these 
sixteen genes inﬂ  uenced by each perturbated ele-
ment αi,j of ∆A in equation (10). For example, if 
we consider the sensitivity of p53 100 in Supple-
mentary Table 2, α1,6, α3,1, α6,5, α11,11, α12,11 of  Ai, j, 
∀i, j = 1 … 16, are the ﬁ  ve perturbated parameters 
that cause the gene expression with the most seri-
ous deviations in equations of Table 3. We can set 
up threshold value of the gene which we choose 
and compare the sensitivity in these perturbated 
elements. Besides, among sixteen genes in one row 
of selected perturbated element such as α1,1 in 
Supplementary Table 2, we can ﬁ  nd that cdk2 and 
ARF are the two genes with the highest sensitivity 
scores by ∆A1,1. The same situation occurs in other 
perturbated elements of ∆A, and we can conclude 
that cdk2 and ARF are the two genes with the high-
est sensitivity under perturbations of A. Therefore, 
perturbations of kinetic changes could illustrate 
which perturbated parameters cause the system the 
most serious variations, and which genes are the 
most sensitive to the perturbated parameters.
Discussion
Linear and nonlinear model 
in biological systems
In this study, we apply the linear model to describe 
multiple feedback loops of p53. Measurement of 
robustness and sensitivity can be easily calculated 
by the linear model, but nonlinear effects in the 
gene network such as DNA-protein complexes are 
neglected. Robustness is measured by eigenvalue 
locations, and three types of sensitivity are gener-
ated directly by perturbated parameters. Although 
linear model is easy and efﬁ  cient to measure robust-
ness and sensitivity compared with the nonlinear 
model, nonlinear biochemical models such as gen-
eralized mass action (GMA) and S-system (Chen 
et al. 2005; Voit and Ferreira, 2000) should be 
developed to measure robustness and sensitivity 
more precisely in future, for example, the oscillation 
Table 3. Sensitivity scores under heat shock, oxidative and ER stress between cancer and normal cells. This 
table provides a snapshot of sensitivity scores with ranking in each condition, where red and bold marks denote 
each gene with higher sensitivity value between cancer and normal cells under one of the three stresses.
Stresses  Heat shock  Oxidative stress  ER stress
Cell  type    Cancer Normal Cancer Normal Cancer Normal
Gene name
p53 0.074  (12)  0.554 (7)  0.05 (12)  0.289 (2)  0.046 (14)  0.488 (2)
ARF  0.228 (6)  0.089 (12)  0.063 (10)  0.092 (11)  0.509 (2)  0.358 (5)
MDM2 5.649  (1)  6.482 (1)  0.288 (2)  0.252 (3)  5.568 (1)  0.432 (3)
p21 0.284  (3)  0.836 (3)  0.107 (6)  0.148 (7)  0.263 (5)  0.376 (4)
cdk2  0.234 (5)  0.118 (10)  0.09 (9)  0.052 (14)  0.351 (4)  0.126 (13)
Rb  0.123  (8) 0.097  (11) 0.04  (13)  0.151 (6)  0.075 (11)  0.154 (11)
MAPK14 0.048  (13)  0.16 (9)  0.101 (7)  2.937 (1)  0.162 (8)  0.076 (15)
Wip-1 0.167  (7)  0.198 (8)  0.111 (5)  0.213 (5)  0.187 (7)  0.326 (6)
Siah-1 0.03  (15)  0.085 (13)  0.126 (3)  0.215 (4)  0.086 (10)  0.053 (16)
β-catenin 0.019  (16)  0.029 (16)  0.038 (14)  0.038 (16)  0.072 (12)  0.189 (9)
PTEN  0.114 (10)  0.08 (14)  0.092 (8)  0.082 (12)  0.068 (13)  0.095 (14)
PIP3  0.118 (9)  0.07 (15)  0.024 (15)  0.094 (10)  0.029 (15)  0.308 (7)
AKT2 0.283  (4)  0.751 (4)  0.011 (16)  0.044 (15)  0.016 (16)  0.13 (12)
CCNG1 0.046  (14)  0.59 (6)  0.057 (11)  0.061 (13)  0.088 (9)  1.062 (1)
PP2A 0.091  (11)  1.214 (2)  0.114 (4)  0.133 (8)  0.196 (6)  0.18 (10)
p73 0.291  (2)  0.738 (5)  1.1 (1)  0.112 (9)  0.506 (3)  0.27 (8)
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in the linear gene network may correspond to the 
limit cycle in the nonlinear gene network.
Robustness-based approach 
to systems-oriented drug design
Diseases can be viewed as the breakdown and 
reestablishment of robustness in normal physio-
logical systems, while cancer can be considered as 
parasitic diseases in which the mechanisms for 
robustness are hijacked for triggering and progres-
sion of the disease state in face of various perturba-
tions including therapeutic interventions (Kitano, 
2007). The robustness-based cancer drug design 
has a speciﬁ  c goal, to ﬁ  nd a set of drug targets with 
specific robustness or sensitivity for which 
combinatorial perturbation produces both efﬁ  cacy 
and selectivity (Chen and Li, 2007).
In Table 3, p53 and MDM2 are two sensitive 
genes between cancer and normal cells, which make 
the two attractive drug targets for new therapies 
(Kitano, 2007). Because p53 can induce tumor cell 
death and p53 function is lost in most cancers, the 
most active avenue is to identify small molecules 
that will allow the reactivation of p53 or block 
MDM2, such as Nutlin-3 which blocks the interac-
tion of p53/MDM2, and HLI98 which directly targets 
the ubiquitin-ligase activity of MDM2 (Vousden and 
Lane, 2007). p73 is also a drug target by its fragility 
in cancer cells, with similar overall structure to p53 
(Vousden and Lane, 2007). If we collect time-
dependent microarray data from patients with several 
Table 4. Eigenvalues of A in equation (3) under heat shock, oxidative and ER stress between cancer and normal 
cells.
  Heat shock  Oxidative stress  ER stress
Cancer cells 0.92783  + 0.41426i  0.24283  0.7943
 0.92783  − 0.41426i  0.86287  0.96309 +  0.11392i
 0.46283  0.88826  + 0.035308i  0.96309 − 0.11392i
 1.0111  0.88826  − 0.035308i  0.8439
 1.0047  0.89148  0.86648
 1.0037  1.0348  + 0.001955i  0.92144
 0.98273  + 0.0087054i  1.0348 − 0.001955i  0.95681
 0.98273  − 0.0087054i  1.0038  1.0124 + 0.0079295i
 0.94724  + 0.010911i  0.99953  1.0124 − 0.0079295i
 0.94724  − 0.010911i  0.99684  0.99941 + 0.016265i
 0.95597  0.95284  + 0.015758i  0.99941 − 0.016265i
 0.90653  0.95284  − 0.015758i  0.96999
 0.92026  + 0.0021752i  0.98335  0.98323 + 0.0024292i
 0.92026  − 0.0021752i  0.97226  0.98323 − 0.0024292i
 0.92632  + 0.00091094i  0.9515  1.0061
 0.92632  − 0.00091094i  0.956  0.99636
Normal cells 0.48721  −0.014164 0.68463
 0.74185  + 0.22662i  1.0906  1.084
 0.74185  − 0.22662i  0.92727 + 0.057957i  0.9792 + 0.070673i
 0.64244  0.92727  − 0.057957i  0.9792 − 0.070673i
 1.0624  + 0.039692i  0.89009  0.8574
 1.0624  − 0.039692i  0.90593  0.87611
 1.0435  1.0257  + 0.023522i  0.89497
 1.0114  1.0257  − 0.023522i  1.0089 + 0.024866i
 0.88929  0.94764  1.0089  − 0.024866i
 0.91228  + 0.0040725i  0.96265 + 0.003333i  0.9308
 0.91228  − 0.0040725i  0.96265 − 0.003333i  0.95419 + 0.017276i
 0.98871  0.95992  0.95419  − 0.017276i
 0.97765  0.99502  0.99376
 0.93514  1.0066  0.9859
 0.96344  1.0041  0.9816
 0.94719  1.0008  0.9758
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types of cancer, we can efﬁ  ciently compute sensitiv-
ity scores by our method, identify possible drug 
targets, and compare predicted cancer drug targets 
in different types of cancer. This method can be 
applied to other gene regulatory network from equa-
tions (3)–(12), and combination of these submodule 
networks is the basis for the robustness-based com-
binational cancer drug therapy (Chen and Li, 2007; 
Kitano, 2007).
In Table 3, sensitivity of MDM2 in cancer cells 
under ER stress is higher than in normal cells, which 
demonstrates the therapeutic strategy for manipulat-
ing the ER stress response. The protein-folding 
compartment of the endoplasmic reticulum (ER) is 
particularly sensitive to disturbances, which may 
trigger apoptosis (Herr and Debatin, 2001). Manipu-
lating the ER stress response of tumor cells is an 
obtrusive therapeutic strategy, which the ER stress 
responses involve transcriptional induction of ER 
chaperones and folding enzymes, translational 
attenuation to prevent further load of proteins into the 
ER, and ER-associated degradation to clear misfolded 
proteins out of the ER (Linder and Shoshan, 2005).
Conclusion
Robustness describes the persistence of the char-
acteristic behavior of the system under perturba-
tions or conditions of uncertainty, and sensitivity 
is considered as the inverse of robustness. Oscil-
lations in multiple feedback loops of p53 with 
almost the same frequency or period are illustrated 
successfully by locations of eigenvalues, and 
robustness tradeoffs in cancer are also demon-
strated in this study. Besides, we also provide three 
types of sensitivity measurement, which are useful 
when estimating system stability and deviations of 
the system by perturbated parameters under differ-
ent stresses. These methods provide linear models 
in robustness-based cancer drug design, and non-
linear models should be considered in future.
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Supplementary Table 1. Estimated parameters in Table 2 between cancer and normal cells under different 
stresses.
Heat shock Oxidative Stress ER stress
Cancer Normal Cancer Normal Cancer Normal
α1,1 1.044 0.7268 0.9574 0.9616 0.9177 1.074
α1,3 −0.1026 0.1134 0.006334 0.1298 −0.04867 0.00081
α1,6 0.05995 0.00317 −0.004416 0.03642 −0.007575 0.1465
α1,7 0.01031 0.6302 0.04509 0.1503 −0.02275 −0.2139
α2,1 −0.1564 0.009837 −0.07192 0.008701 0.5371 −0.03559
α2,2 0.8959 0.9048 0.8932 0.957 1.07 0.8758
α2,10 −0.1103 −0.003157 0.102 −0.03569 −0.02597 −0.3406
α3,1 1.745 −0.3639 −0.7279 0.07657 0.2551 0.09949
α3,2 0.429 2.362 0.8698 −0.2835 0.1324 −0.1144
α3,3 0.8536 0.6808 0.2286 0.9705 0.8011 0.9916
α3,5 0.545 −1.227 0.6009 0.01383 0.006959 0.2713
α3,6 0.3013 −0.1417 0.3345 0.1314 −0.1614 −0.02891
α3,13 0.775 1.028 −0.1643 0.2014 0.1074 −0.0713
α3,15 0.4395 0.3443 −0.639 −0.1043 −0.1206 0.1221
α3,16 0.4395 0.3443 −0.06912 0.1243 0.0601 0.08655
α4,1 0.04386 −0.4518 −0.02878 −0.05007 −1.154 0.0642
α4,4 1.007 1.035 0.9609 1.088 0.9964 0.9234
α5,4 0.02466 −0.00941 −0.04889 0.01455 0.0166 0.01825
α5,5 0.9195 0.9364 0.9619 1.009 0.8492 1.038
α6,5 −0.01429 −0.01426 0.01484 −0.03123 0.003516 0.1004
α6,6 0.9076 0.9634 0.9975 0.9633 0.9813 0.9205
α7,7 0.9559 0.9505 0.8771 −0.003746 0.9712 0.9715
α7,8 −0.008813 0.116 −0.03773 0.9206 −0.0272 −0.008996
α8,1 0.04043 0.08352 −0.06336 −0.06863 −0.4614 −0.03286
α8,8 1.004 0.95 0.9101 0.9299 0.838 0.9771
α9,1 0.01675 −0.02692 0.1083 −0.03747 0.2844 0.004906
α9,9 0.9792 0.9774 0.9507 0.894 0.9698 0 0.9758
α10,9 −0.008387 0.02753 0.004947 0.003376 −0.009407 −0.05058
α10,10 0.9849 0.9891 1.034 1.003 1.01 0.8575
α11,1 0.004463 −0.02747 0.08688 −0.01919 −0.2498 −0.009152
α11,11 0.9275 0.9473 0.973 0.96 0.9991 0.9859
α12,11 0.4629 0.4408 0.03193 0.006276 −0.07244 −0.004912
α12,12 0.4629 0.4408 0.9559 1.006 0.9513 0.9308
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Heat shock Oxidative Stress ER stress
Cancer Normal Cancer Normal Cancer Normal
α13,12 0.04349 −0.5637 0.004907 0.002787 0.0072 −0.04064
α13,13 0.9519 0.8627 1 0.9959 0.9985 0.9816
α14,1 0.02952 −0.05729 −0.005054 0.01943 0.05795 0.1241
α14,14 1.009 1.052 1.004 1 0.9891 0.6846
α15,14 −0.02022 0.01556 −0.03691 −0.05527 0.03189 −0.0311
α15,15 0.9266 0.8891 0.8629 0.9462 1.004 0.9938
α16,1 −0.0004636 −0.04371 0.3009 0.0124 0.2117 0.046
α16,13 −0.005901 −0.0002026 0.103 0.01417 −0.1269 −0.05952
α16,14 −0.01709 0.05491 0.03214 −0.06075 0.07642 −0.07678
α16,16 0.924 1.013 1.045 0.937 0.925 0.9677
β1 0.01208 −0.335 −0.002459 −0.1463 −0.002459 −0.003217
β2 0.1753 0.05707 0.04106 0.04027 0.04106 0.2366
β3 −2.499 −1.083 0.2417 −0.08982 0.2417 −0.1813
β4 −0.01477 0.1958 0.03316 −0.009949 0.03316 0.0329
β5 0.07958 0.04697 0.04301 −0.01343 0.04301 −0.03471
β6 0.06151 0.0233 −0.007604 0.03372 −0.007604 0.002424
β7 0.02485 −0.04106 0.08378 0.04512 0.08378 0.02556
β8 −0.01578 −0.009031 0.07676 0.07833 0.07676 0.05326
β9 0.001499 0.02581 −0.03155 0.07065 −0.03155 0.01194
β10 0.01053 −0.003166 −0.02052 −0.004804 −0.02052 0.0951
β11 0.03175 0.03484 −0.03126 0.03382 −0.03126 0.01811
β12 0.03461 0.04657 0.005745 −0.01031 0.005745 0.0334
β13 0.0001118 0.2914 −0.003158 −0.001051 −0.003158 0.03189
β14 −0.0173 −0.01331 0.003529 −0.01026 0.003529 0.07618
β15 0.04294 0.03025 0.09271 0.04081 0.09271 0.02294
β16 0.04687 −0.02949 −0.2458 0.05101 −0.2458 0.07875
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